Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer

Martina Troiani^#^{1

2

3}, Manuel Colucci^#^{1

2

4}, Mariantonietta D'Ambrosio^{1

2

4}, Ilaria Guccini⁵, Emiliano Pasquini^{1

2}, Angelica Varesi^{1

2}, Aurora Valdata^{1

2}, Simone Mosole^{1

2}, Ajinkya Revandkar^{1

2

6}, Giuseppe Attanasio^{1

2}, Andrea Rinaldi^{1

2}, Anna Rinaldi^{7

8}, Marco Bolis^{1

2

3

9}, Pietro Cippà^{7

8}, Andrea Alimonti^{10

11

12

13}

Affiliations

¹ Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), CH6500, Bellinzona, Switzerland.
² Università della Svizzera Italiana, CH6900, Lugano, Switzerland.
³ Bioinformatics Core Unit, Swiss Institute of Bioinformatics, TI, 6500, Bellinzona, Switzerland.
⁴ Faculty of Biology and Medicine, University of Lausanne UNIL, CH1011, Lausanne, Switzerland.
⁵ Institute of Molecular Health Sciences, ETH Zurich, CH8093, Zurich, Switzerland.
⁶ Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA.
⁷ Department of Medicine, Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
⁸ Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
⁹ Computational Oncology Unit, Department of Oncology, Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, 20156, Milano, Italy.
¹⁰ Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), CH6500, Bellinzona, Switzerland. andrea.alimonti@ior.usi.ch.
¹¹ Università della Svizzera Italiana, CH6900, Lugano, Switzerland. andrea.alimonti@ior.usi.ch.
¹² Department of Health Sciences and Technology (D-HEST) ETH Zurich, 8093, Zurich, CH, Switzerland. andrea.alimonti@ior.usi.ch.
¹³ Department of Medicine & Veneto Institute of Molecular Medicine, University of Padova, Padova, Italy. andrea.alimonti@ior.usi.ch.

^# Contributed equally.

PMID: 37474528
PMCID: PMC10359282
DOI: 10.1038/s41467-023-40080-9

Published Erratum

Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer

Martina Troiani et al. Nat Commun. 2023.

. 2023 Jul 20;14(1):4386.

doi: 10.1038/s41467-023-40080-9.

Authors

Affiliations

¹ Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), CH6500, Bellinzona, Switzerland.
² Università della Svizzera Italiana, CH6900, Lugano, Switzerland.
³ Bioinformatics Core Unit, Swiss Institute of Bioinformatics, TI, 6500, Bellinzona, Switzerland.
⁴ Faculty of Biology and Medicine, University of Lausanne UNIL, CH1011, Lausanne, Switzerland.
⁵ Institute of Molecular Health Sciences, ETH Zurich, CH8093, Zurich, Switzerland.
⁶ Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA.
⁷ Department of Medicine, Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
⁸ Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
⁹ Computational Oncology Unit, Department of Oncology, Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, 20156, Milano, Italy.
¹⁰ Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), CH6500, Bellinzona, Switzerland. andrea.alimonti@ior.usi.ch.
¹¹ Università della Svizzera Italiana, CH6900, Lugano, Switzerland. andrea.alimonti@ior.usi.ch.
¹² Department of Health Sciences and Technology (D-HEST) ETH Zurich, 8093, Zurich, CH, Switzerland. andrea.alimonti@ior.usi.ch.
¹³ Department of Medicine & Veneto Institute of Molecular Medicine, University of Padova, Padova, Italy. andrea.alimonti@ior.usi.ch.

^# Contributed equally.

PMID: 37474528
PMCID: PMC10359282
DOI: 10.1038/s41467-023-40080-9

No abstract available

PubMed Disclaimer

Erratum for

Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer.
Troiani M, Colucci M, D'Ambrosio M, Guccini I, Pasquini E, Varesi A, Valdata A, Mosole S, Revandkar A, Attanasio G, Rinaldi A, Rinaldi A, Bolis M, Cippà P, Alimonti A. Troiani M, et al. Nat Commun. 2022 Apr 21;13(1):2177. doi: 10.1038/s41467-022-29824-1. Nat Commun. 2022. PMID: 35449130 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer

Affiliations

Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources